List of Tables
Table 1. Global Covid-19 Serology Testing Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Covid-19 Serology Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Covid-19 Serology Testing Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Covid-19 Serology Testing Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Covid-19 Serology Testing Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Covid-19 Serology Testing Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Covid-19 Serology Testing Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Covid-19 Serology Testing Revenue by Company (2020-2025) & (US$ Million)
Table 11. Covid-19 Serology Testing Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Covid-19 Serology Testing Players by Revenue (US$ Million) in 2024
Table 13. Global Covid-19 Serology Testing Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Covid-19 Serology Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Covid-19 Serology Testing as of 2024)
Table 15. Global Covid-19 Serology Testing Companies Headquarters
Table 16. Date of International Companies Enter into Covid-19 Serology Testing Market
Table 17. Global Covid-19 Serology Testing Companies Product & Service
Table 18. Global Covid-19 Serology Testing Mergers & Acquisitions, Expansion Plans
Table 19. Abbott Corporation Information
Table 20. Abbott Description and Business Overview
Table 21. Abbott Covid-19 Serology Testing Product
Table 22. Abbott Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Abbott Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 24. Abbott Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 25. Abbott Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 26. Abbott Recent Developments
Table 27. Guangzhou Wondfo Biotech Corporation Information
Table 28. Guangzhou Wondfo Biotech Description and Business Overview
Table 29. Guangzhou Wondfo Biotech Covid-19 Serology Testing Product
Table 30. Guangzhou Wondfo Biotech Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Guangzhou Wondfo Biotech Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 32. Guangzhou Wondfo Biotech Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 33. Guangzhou Wondfo Biotech Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 34. Guangzhou Wondfo Biotech Recent Developments
Table 35. BioMedomics Corporation Information
Table 36. BioMedomics Description and Business Overview
Table 37. BioMedomics Covid-19 Serology Testing Product
Table 38. BioMedomics Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. BioMedomics Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 40. BioMedomics Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 41. BioMedomics Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 42. BioMedomics Recent Developments
Table 43. Kantaro Corporation Information
Table 44. Kantaro Description and Business Overview
Table 45. Kantaro Covid-19 Serology Testing Product
Table 46. Kantaro Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Kantaro Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 48. Kantaro Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 49. Kantaro Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 50. Kantaro Recent Developments
Table 51. Roche Corporation Information
Table 52. Roche Description and Business Overview
Table 53. Roche Covid-19 Serology Testing Product
Table 54. Roche Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. Roche Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 56. Roche Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 57. Roche Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 58. Roche Recent Developments
Table 59. Cellex Corporation Information
Table 60. Cellex Description and Business Overview
Table 61. Cellex Covid-19 Serology Testing Product
Table 62. Cellex Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. Cellex Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 64. Cellex Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 65. Cellex Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 66. Cellex Recent Developments
Table 67. Innovita Biological Technology Corporation Information
Table 68. Innovita Biological Technology Description and Business Overview
Table 69. Innovita Biological Technology Covid-19 Serology Testing Product
Table 70. Innovita Biological Technology Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Innovita Biological Technology Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 72. Innovita Biological Technology Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 73. Innovita Biological Technology Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 74. Innovita Biological Technology Recent Developments
Table 75. Zhejiang Orient Gene Biotech Corporation Information
Table 76. Zhejiang Orient Gene Biotech Description and Business Overview
Table 77. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Product
Table 78. Zhejiang Orient Gene Biotech Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. Zhejiang Orient Gene Biotech Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 80. Zhejiang Orient Gene Biotech Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 81. Zhejiang Orient Gene Biotech Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 82. Zhejiang Orient Gene Biotech Recent Developments
Table 83. Ortho Clinical Diagnostics Corporation Information
Table 84. Ortho Clinical Diagnostics Description and Business Overview
Table 85. Ortho Clinical Diagnostics Covid-19 Serology Testing Product
Table 86. Ortho Clinical Diagnostics Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. Ortho Clinical Diagnostics Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 88. Ortho Clinical Diagnostics Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 89. Ortho Clinical Diagnostics Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 90. Ortho Clinical Diagnostics Recent Developments
Table 91. Guangdong Hecin-Scientific Corporation Information
Table 92. Guangdong Hecin-Scientific Description and Business Overview
Table 93. Guangdong Hecin-Scientific Covid-19 Serology Testing Product
Table 94. Guangdong Hecin-Scientific Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Guangdong Hecin-Scientific Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 96. Guangdong Hecin-Scientific Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 97. Guangdong Hecin-Scientific Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 98. Guangdong Hecin-Scientific Recent Developments
Table 99. Dynamiker Biotechnology (Tianjin) Corporation Information
Table 100. Dynamiker Biotechnology (Tianjin) Description and Business Overview
Table 101. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Product
Table 102. Dynamiker Biotechnology (Tianjin) Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Dynamiker Biotechnology (Tianjin) Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 104. Dynamiker Biotechnology (Tianjin) Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 105. Dynamiker Biotechnology (Tianjin) Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 106. Dynamiker Biotechnology (Tianjin) Recent Developments
Table 107. Chembio Diagnostics Corporation Information
Table 108. Chembio Diagnostics Description and Business Overview
Table 109. Chembio Diagnostics Covid-19 Serology Testing Product
Table 110. Chembio Diagnostics Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Chembio Diagnostics Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 112. Chembio Diagnostics Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 113. Chembio Diagnostics Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 114. Chembio Diagnostics Recent Developments
Table 115. Safecare Bio-Tech Corporation Information
Table 116. Safecare Bio-Tech Description and Business Overview
Table 117. Safecare Bio-Tech Covid-19 Serology Testing Product
Table 118. Safecare Bio-Tech Covid-19 Serology Testing Revenue (US$ Million) and Gross Margin (2020-2025)
Table 119. Safecare Bio-Tech Revenue Proportion of Covid-19 Serology Testing by Product in 2024
Table 120. Safecare Bio-Tech Revenue Proportion of Covid-19 Serology Testing by Application in 2024
Table 121. Safecare Bio-Tech Revenue Proportion of Covid-19 Serology Testing by Geographic Area in 2024
Table 122. Safecare Bio-Tech Recent Developments
Table 123. North America Covid-19 Serology Testing Revenue by Country (2020-2025) & (US$ Million)
Table 124. North America Covid-19 Serology Testing Revenue by Country (2026-2031) & (US$ Million)
Table 125. North America Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 126. North America Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 127. Asia-Pacific Covid-19 Serology Testing Revenue by Region (2020-2025) & (US$ Million)
Table 128. Asia-Pacific Covid-19 Serology Testing Revenue by Region (2026-2031) & (US$ Million)
Table 129. Asia-Pacific Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 130. Asia-Pacific Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 131. Europe Covid-19 Serology Testing Revenue by Country (2020-2025) & (US$ Million)
Table 132. Europe Covid-19 Serology Testing Revenue by Country (2026-2031) & (US$ Million)
Table 133. Europe Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 134. Europe Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 135. Latin America Covid-19 Serology Testing Revenue by Country (2020-2025) & (US$ Million)
Table 136. Latin America Covid-19 Serology Testing Revenue by Country (2026-2031) & (US$ Million)
Table 137. Latin America Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 138. Latin America Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 139. Middle East and Africa Covid-19 Serology Testing Revenue by Country (2020-2025) & (US$ Million)
Table 140. Middle East and Africa Covid-19 Serology Testing Revenue by Country (2026-2031) & (US$ Million)
Table 141. Middle East and Africa Covid-19 Serology Testing Revenue by Type (2020-2025) & (US$ Million)
Table 142. Middle East and Africa Covid-19 Serology Testing Revenue by Application (2020-2025) & (US$ Million)
Table 143. Covid-19 Serology Testing Key Raw Materials, Industry Status and Trend
Table 144. Covid-19 Serology Testing Key Raw Materials and Upstream Suppliers
Table 145. Covid-19 Serology Testing Clients Status and Trend
Table 146. Covid-19 Serology Testing Typical Clients
Table 147. Covid-19 Serology Testing Distributors
Table 148. Covid-19 Serology Testing Market Trends
Table 149. Covid-19 Serology Testing Market Drivers
Table 150. Covid-19 Serology Testing Market Challenges
Table 151. Covid-19 Serology Testing Market Restraints
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Covid-19 Serology Testing Product Picture
Figure 2. Global Covid-19 Serology Testing Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Covid-19 Serology Testing Revenue Market Share by Type in 2024 & 2031
Figure 4. Rapid Diagnostic Test (RDT) Product Picture
Figure 5. Chemiluminescent Immunoassay Product Picture
Figure 6. Other Product Picture
Figure 7. Global Covid-19 Serology Testing Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 8. Global Covid-19 Serology Testing Revenue Market Share by Application in 2024 & 2031
Figure 9. Hospitals
Figure 10. Third-party laboratory
Figure 11. Covid-19 Serology Testing Report Years Considered
Figure 12. Global Covid-19 Serology Testing Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 13. Global Covid-19 Serology Testing Market Size (2020-2031) & (US$ Million)
Figure 14. Global Covid-19 Serology Testing Market Size Market Share by Region: 2024 Versus 2031
Figure 15. Global Covid-19 Serology Testing Revenue Market Share by Region (2020-2031)
Figure 16. Global Covid-19 Serology Testing Revenue Market Share Forecast by Type (2020-2031)
Figure 17. Global Covid-19 Serology Testing Revenue Market Share Forecast by Application (2020-2031)
Figure 18. Rapid Diagnostic Test (RDT) of Covid-19 Serology Testing Revenue Market Share by Application, 2024 VS 2031
Figure 19. Chemiluminescent Immunoassay of Covid-19 Serology Testing Revenue Market Share by Application, 2024 VS 2031
Figure 20. Other of Covid-19 Serology Testing Revenue Market Share by Application, 2024 VS 2031
Figure 21. Covid-19 Serology Testing Revenue Share by Company (2024)
Figure 22. Covid-19 Serology Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 23. Rapid Diagnostic Test (RDT) Revenue Proportion by Company in 2024
Figure 24. Chemiluminescent Immunoassay Revenue Proportion by Company in 2024
Figure 25. Other Revenue Proportion by Company in 2024
Figure 26. North America Covid-19 Serology Testing Revenue 2020-2031 (US$ Million)
Figure 27. North America Covid-19 Serology Testing Revenue Market Share by Type (2020-2025)
Figure 28. North America Covid-19 Serology Testing Revenue Market Share by Application (2020-2025)
Figure 29. Asia-Pacific Covid-19 Serology Testing Revenue 2020-2031 (US$ Million)
Figure 30. Asia-Pacific Covid-19 Serology Testing Revenue Market Share by Region (2020-2031)
Figure 31. Asia-Pacific Covid-19 Serology Testing Revenue Market Share by Type (2020-2025)
Figure 32. Asia-Pacific Covid-19 Serology Testing Revenue Market Share by Application (2020-2025)
Figure 33. Europe Covid-19 Serology Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 34. Europe Covid-19 Serology Testing Revenue Market Share by Country (2020-2031)
Figure 35. Europe Covid-19 Serology Testing Revenue Market Share by Type (2020-2025)
Figure 36. Europe Covid-19 Serology Testing Revenue Market Share by Application (2020-2025)
Figure 37. Latin America Covid-19 Serology Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 38. Latin America Covid-19 Serology Testing Revenue Market Share by Country (2020-2031)
Figure 39. Latin America Covid-19 Serology Testing Revenue Market Share by Type (2020-2025)
Figure 40. Latin America Covid-19 Serology Testing Revenue Market Share by Application (2020-2025)
Figure 41. Middle East and Africa Covid-19 Serology Testing Revenue Growth Rate 2020-2031 (US$ Million)
Figure 42. Middle East and Africa Covid-19 Serology Testing Revenue Market Share by Country (2020-2031)
Figure 43. Middle East and Africa Covid-19 Serology Testing Revenue Market Share by Type (2020-2025)
Figure 44. Middle East and Africa Covid-19 Serology Testing Revenue Market Share by Application (2020-2025)
Figure 45. Covid-19 Serology Testing Supply Chain (Upstream and Downstream Market)
Figure 46. Global Production Market Share of Covid-19 Serology Testing Raw Materials by Region in 2024
Figure 47. Covid-19 Serology Testing Distribution Channels
Figure 48. Global Covid-19 Serology Testing Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 49. Global Covid-19 Serology Testing Percentage 2020-2031: Online Sales VS Offline Sales
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed